FlowCell
FlowCell
  • Home
  • About
    • Mission
    • History
    • Company Leaders
    • Board of Directors
  • Our Products
    • FluidsForLife.com
    • Modeling and Prototyping
  • Investor Relations
  • News and Resources
    • Blog
    • MicroPhysiological System
    • Physiological Model
    • Areas of Research
  • More
    • Home
    • About
      • Mission
      • History
      • Company Leaders
      • Board of Directors
    • Our Products
      • FluidsForLife.com
      • Modeling and Prototyping
    • Investor Relations
    • News and Resources
      • Blog
      • MicroPhysiological System
      • Physiological Model
      • Areas of Research
  • Home
  • About
  • Our Products
  • Investor Relations
  • News and Resources

The Leaders of FlowCell

Max Narovlyansky CEO of Flowcell

Max Narovlyansky

Founder and CEO


 Max is a scientist who is passionate about technologies for healthcare. He is contributing his knowledge about drug development, biomarkers, and microfluidics to precision medicine.

Jonas Moses COO of Flowcell

Jonas Moses

COO


More than 25 years of translational research, life sciences, cancer biology, laboratory science, regulatory compliance, tech transfer brought to bear in Biotech, Pharma, Biopharma, Medical Device, pre-clinical/clinical trials. Industry, Academia and Government roles. Multiple patents, published scientist and book author, “Bio-engineering of a 3D In Vitro Tumor Model.

Mark Wesson CFO of Flowcell

Mark Wesson

CFO


Mark Wesson has experience leading analysis and restructuring of the programs to improve the quality of care for patients. He’s also skilled at cultivating innovation using the latest technologies to improve information management and communication. Over his 20-year career, Mark has designed, conducted, managed, analyzed, or reported many health care projects.

He has disseminated many of the resulting data-driven program proposals and reports directly to providers or senior health care executives. Mark worked with providers, executives, and support staff across the continuum of care within the emergency, inpatient, and outpatient care delivery settings. He simultaneously project managed, coordinated, or consulted on analytic, strategic, financial, operational, or system administration responsibilities.

Lahiri Nanduri CSO of Flowcell

Lahiri K. Nanduri, PhD

CSO


Lahiri Nanduri is a biologist with over 15 years of expertise in single-cell methods for oncology. He has lots of publications known as an SME in this field. Lahiri has worked in multiple organizations with organoids, biobanking, and evaluating cutting-edge tools. 


 Copyright © 2021 FlowCell - All Rights Reserved.